The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); Bayer (Inst); Becton Dickinson (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celldex (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Pacira Pharmaceuticals (Inst); Pfizer (Inst); Sanofi (Inst); Shire (Inst); Takeda (Inst)
Assessing the quality-adjusted time without symptoms of disease progression or toxicity (Q-TWiST) in immuno-oncology (I/O): An application to nivolumab vs. everolimus in previously treated advanced renal cell carcinoma (aRCC).
 
Ruchit Shah
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); Bayer (Inst); Becton Dickinson (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celldex (Inst); Merck Sharp & Dohme (Inst); Pacira Pharmaceuticals (Inst); Pfizer (Inst); Sanofi (Inst); Shire (Inst); Takeda (Inst)
 
Marc Botteman
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); Bayer (Inst); Becton Dickinson (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celldex (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Pacira Pharmaceuticals (Inst); Pfizer (Inst); Sanofi (Inst); Shire (Inst); Takeda (Inst)
 
Caitlyn Solem
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); Bayer (Inst); Becton Dickinson (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celldex (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Pacira Pharmaceuticals (Inst); Pfizer (Inst); Sanofi (Inst); Shire (Inst); Takeda (Inst)
 
Linlin Luo
No Relationships to Disclose
 
Justin Doan
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
David Cella
Stock and Other Ownership Interests - FACIT.org
Consulting or Advisory Role - Abbvie; Astellas Pharma; Bayer; GlaxoSmithKline; Novartis; Pfizer; PledPharma; Puma Biotechnology
Research Funding - Bayer (Inst); Genentech (Inst); Ipsen (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Ipsen
 
Robert J. Motzer
Consulting or Advisory Role - Eisai; Exelixis; Merck; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst)